Glacier Peak Capital’s Amgen AMGN Stock Holding History

Glacier Peak Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$286K	Sell	1,476 -150	-9%	-$28.8K	0.3%	57
2019 Q2	$300K	Hold	1,626	–	–	0.28%	57
2019 Q1	$309K	Buy	+1,626	New	+$311K	0.28%	57
2016 Q1	–	Sell	-17,000	Closed	-$2.76M	–	43
2015 Q4	$2.76M	Hold	17,000	–	–	1.76%	18
2015 Q3	$2.35M	Hold	17,000	–	–	1.3%	24
2015 Q2	$2.61M	Hold	17,000	–	–	1.32%	25
2015 Q1	$2.72M	Hold	17,000	–	–	1.33%	27
2014 Q4	$2.71M	Sell	17,000 -2,000	-11%	-$312K	1.37%	25
2014 Q3	$2.67M	Buy	19,000 +10,000	+111%	+$1.31M	1.47%	24
2014 Q2	$1.06M	Buy	+9,000	New	+$1.04M	0.66%	36

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Glacier Peak Capital's AMGN Position: Q3 2019 in Review

Glacier Peak Capital reduced its Amgen (AMGN) stake by 9.2% in Q3 2019, selling an estimated $28.8K and leaving 1,476 shares worth $286K. The position accounts for 0.3% of the portfolio, ranked #57.

Glacier Peak Capital first reported a position in AMGN in Q2 2014 and has held it in 10 quarters since. The position peaked at $2.76M in Q4 2015. 1,884 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

Glacier Peak Capital held 1,476 shares of Amgen worth $286K as of Q3 2019.
Glacier Peak Capital sold 150 Amgen shares in Q3 2019, an estimated $28.8K.
Amgen made up 0.3% of Glacier Peak Capital's portfolio in Q3 2019, its #57 holding.
Glacier Peak Capital first reported a position in Amgen in Q2 2014 and has held it in 10 quarters since.
Glacier Peak Capital's Amgen position peaked at $2.76M in Q4 2015.
1,884 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Glacier Peak Capital's 13F filing for Q3 2019, filed 12 Nov 2019.